What to Do When a Fund Manager Leaves
When do you stick with the old fund, and when do you move your money to a new one? It's often a difficult choice.
One of the toughest decisions a mutual fund investor has to make is what to do when a manager departs. Should you stick with the fund you've liked for years, or should you follow one of the managers to his or her new shop? What about when a manager retires or dies? Should you hold your shares or sell?
All of a fund's past returns are called into question. How much of the good returns was the work of the manager who's no longer there? You have to make a judgment call, and often it's not easy.
Take Matthews Asian Growth & Income (symbol MACSX) and Seafarer Overseas Growth & Income (SFGIX). Last year, Andrew Foster left the Matthews fund, which he had co-managed since 2005, to launch Seafarer. Foster had also served at various times as acting chief investment officer and director of research at Matthews.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Foster, 38, is smart, has a lot of experience investing in emerging markets and strikes me as a savvy investor. But Matthews has been around for many years and boasts a deep and talented team of analysts and managers -- and none have yet followed Foster to Seafarer. I see little reason to unload Matthews Growth & Income or my favorite of the firm's low-risk funds, Matthews Asia Dividend (MAPIX), a member of the Kiplinger 25 (see Emerging Markets Are Still a Bargain for more on Matthews Asia Dividend). Seafarer, which invests in emerging markets all over the world, not just in Asia, is worth watching.
It's a different story, I think, with Wasatch and Grandeur Peak, both based in Salt Lake City. Wasatch was terrific when it was smaller, and it still boasts some first-rate funds that specialize in small, fast-growing companies. But when Robert Gardiner, who had 30 years experience at Wasatch, left the firm and launched Grandeur Peak Global Opportunities (GPGOX) and Grandeur Peak International Opportunities (GPIOX) late last year, his staff of nine included eight former Wasatch employees. All four of his analysts came from Wasatch.
The new firm pledges to stay small. Global will likely close to new investors at $400 million in assets, and International at $350 million (they currently have $159 million and $65 million, respectively). The firm should be able to manage $2 billion without encountering the problems usually associated with asset bloat. This is just what you want to hear from managers specializing in small companies, which can be hard to trade in large quantities.
Sometimes the decision is pretty easy. Primecap Odyssey Growth (POGRX), a favorite of mine, lost one of its founding managers, Howard Schow, who died last April. But Schow left behind his co-founders. What's more, the old team has trained a new generation of analysts and managers. Odyssey Growth is a keeper.
It was a different story when Richard Aster, who had managed Meridian Growth (MERDX) since its inception in 1984, died last February. The team now running the fund all have Meridian experience, but Aster was the fund's guiding light. It's hard to know how the fund will do over time. I'd look elsewhere.
The same goes for Columbia Value & Restructuring A (EVRAX), which Dave Williams ran for almost 20 years before retiring last April. His two co-managers have been on the job since 2009, but the fund is now a question mark. I see little reason to stay with it.
When Jeffrey Gundlach was fired as manager of TCW Total Return (TGMNX) in December 2009, it presented investors with a different set of issues. A bitter legal battle ensued after Gundlach launched DoubleLine Total Return (DBLTX), another member of the Kiplinger 25 (see Is DoubleLine Total Return Bond Fund Too Risky?).
Gundlach had managed the TCW fund since 1993. Moreover, a large number of people left TCW to join him at DoubleLine. Gundlach's returns since 1993, including those at DoubleLine, give him reason to boast.
Sometimes departures leave you with nearly impossible decisions. Since Michael Price left Franklin Mutual Series funds in 1998, the firm has had a succession of managers. With every departure, I've struggled to figure out how much talent walked out the door and how much remained at Mutual Series.
Among the alumni, David Winters, manager of Wintergreen Fund (WGRNX), has put up superb numbers. But David Marcus launched Evermore Global Value (EVGBX), and it hasn't done so well.
My choice? I still like Mutual Global Discovery, one of the original Price funds, particularly if you can buy the no-load class Z shares (MDISX). Franklin Mutual Series funds (except the grandfathered Z shares), as well as Evermore, carry a sales charge. Mutual Series has a deep bench of analysts, who I think still have the mojo.
But Winters has done a bang-up job, too, so I could be wrong. As I said at the outset, these decisions aren't easy ones. Don't expect to be right all the time.
Steven T. Goldberg is an investment adviser in the Washington, D.C. area.
Kiplinger's Investing for Income will help you maximize your cash yield under any economic conditions. Subscribe now!
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.
-
Stock Market Today: Stocks End Higher in Whipsaw Session
The main indexes were volatile Thursday with Nvidia earnings in focus.
By Karee Venema Published
-
Trump Picks Dr. Oz as Head of Medicare and Medicaid
President-elect Donald Trump picked Dr. Mehmet Oz to lead the Centers for Medicare and Medicaid Services. Here's what to know about the former TV host.
By Kathryn Pomroy Published
-
ESG Gives Russia the Cold Shoulder, Too
ESG MSCI jumped on the Russia dogpile this week, reducing the country's ESG government rating to the lowest possible level.
By Ellen Kennedy Published
-
Morningstar Fund Ratings Adopt a Stricter Curve
investing Morningstar is in the middle of revamping its fund analysts' methodology. Can they beat the indices?
By Steven Goldberg Published
-
Market Timing: The Importance of Doing Nothing
Investor Psychology Investors, as a whole, actually earn less than the funds that they invest in. Here’s how to avoid that fate.
By Steven Goldberg Published
-
Commission-Free Trades: A Bad Deal for Investors
investing Four of the biggest online brokers just cut their commissions to $0 per transaction. Be careful, or you could be a big loser.
By Steven Goldberg Published
-
Vanguard Dividend Growth Reopens. Enter at Will.
investing Why you should consider investing in this terrific fund now.
By Steven Goldberg Published
-
Health Care Stocks: Buy Them While They're Down
investing Why this sector should outperform for years to come
By Steven Goldberg Published
-
Buy Marijuana Stocks Now? You'd Have to Be Stoned.
stocks Don't let your investment dollars go to pot
By Steven Goldberg Published
-
4 Valuable Lessons From the 10-Year Bull Market
Investor Psychology Anything can happen next, so you must be mentally prepared.
By Steven Goldberg Published